3136 results for «2669»
3136 results
Mitral valve - How to evaluate?
11 Sep 2025 – From PCR Rio Valves 2025
This educational session focuses on comprehensive evaluation of the mitral valve to guide clinical decision-making. Topics include risk stratification and patient selection for Mitral TEER, detailed anatomy review, assessment of primary and secondary mitral regurgitation phenotypes, advanced quantification techniques per current guidelines, and pre-intervention transoesophageal echocardiography...
Valve-in-valve and coronary protection
11 Sep 2025 – From PCR Rio Valves 2025
Explore complex valve-in-valve procedures and coronary protection strategies through a series of challenging case presentations. Topics include management of high-risk valve-in-valve scenarios, strategies for degenerated aortic bioprostheses, innovative transcarotid approaches, fenestration stenting for late coronary obstruction, and analysis of valve embolisation events, providing valuable insights for...
Orthotopic mitral devices coming soon
12 Sep 2025 – From PCR Rio Valves 2025
This session provides a forward-looking perspective on emerging orthotopic mitral valve devices for repair and replacement. Discussions focus on new device technologies soon to be available, patient selection criteria, and the specific developmental challenges encountered. Case presentations, including the TVMR Intrepid system, illustrate clinical applications and...
Management of residual and recurrent mitral regurgitation after TEER
12 Sep 2025 – From PCR Rio Valves 2025
Delve into the complexities of managing residual and recurrent mitral regurgitation following Transcatheter Edge-to-Edge Repair (TEER). This session discusses challenges such as late mitral regurgitation, strategies for handling single leaflet detachment, and anatomical considerations that may preclude TEER feasibility.
Integrating the newest valve guidelines into daily clinical reality
12 Sep 2025 – From PCR Rio Valves 2025
Integrate the 2025 EACTS valve guidelines into your clinical practice with a focus on valvular heart disease management tailored to Latin American realities. This session reviews the most relevant updates on aortic stenosis management and transcatheter approaches for mitral and tricuspid valves.
Watch the interview with Fabien...
TAVI - Take the first step considering life time management
12 Sep 2025 – From PCR Rio Valves 2025
Understand the critical importance of lifetime management in TAVI, emphasizing how the initial procedure impacts long-term results. This session discusses implantation depth, commissural alignment, and their roles beyond coronary access, illustrated through a low-risk young patient case and current durability data.
Expanding horizons with balloon-expandable TAVI - LIVE Case
12 Sep 2025 – From PCR Rio Valves 2025
A 76-year-old male with a history of abdominal and iliac stent grafts (2022), severe COPD, prostate cancer, and gastric ulcer presented with symptomatic severe aortic stenosis. CT and echocardiography showed a calcified bicuspid aortic valve with preserved LV function.
A 24.5 mm Myval valve was implanted without...
TAVI in challenging scenarios, diving into real-life cases
12 Sep 2025 – From PCR Rio Valves 2025
Navigate the complexities of challenging TAVI cases through real-life clinical scenarios. This session offers valuable insights into managing complications such as aortic regurgitation, bicuspid valves, valve-in-valve procedures, coronary obstruction, and large annulus with left ventricular outflow tract calcification. Participants will gain practical tips and tricks to...
Innovations in aortic valves
11 Sep 2025 – From PCR Rio Valves 2025
Discover the latest innovations in aortic valve technology in this comprehensive session. Explore initial clinical experiences with new self-expandable valves in small annuli, mid-term durability data of novel prostheses, and cutting-edge developments such as silver nanoparticle-coated valves and vascular protection implantable systems, providing a forward-looking perspective...
Aortic stenosis doesn't play alone: TAVI in multivalvular and coronary artery disease patients
11 Sep 2025 – From PCR Rio Valves 2025
Managing aortic stenosis becomes even more challenging when it coexists with coronary artery disease (CAD) or multivalvular pathology. For patients with CAD, careful assessment of symptoms, lesion severity, and anatomy guides whether PCI is best performed before, during, or after TAVI, always with future coronary access...
Seal the deal: echocardioraphy-guided LAA closure for stroke defense
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on echocardiography-guided left atrial appendage (LAA) closure as a critical strategy for stroke prevention. Attendees will explore optimal cardiac imaging techniques tailored to evolving clinical needs and seasonal considerations. The session also includes comprehensive instruction on post-procedural echocardiographic assessment and post-processing workflows in...
Tricuspid and mitral: fine tuning diagnosis and results in transcatheter valve management
11 Sep 2025 – From PCR Rio Valves 2025
This session focuses on refining diagnosis and treatment outcomes in transcatheter management of tricuspid and mitral valves. Topics include assessment of pulmonary artery pressure changes post-MitraClip, 3D echocardiographic evaluation of tricuspid regurgitation severity, quantitative improvements in imaging, and insights from single-centre experiences. Additional discussions cover bicaval...
Tricuspid valve - Present and future perspectives: a critical appraisal
12 Sep 2025 – From PCR Rio Valves 2025
Explore the cutting-edge developments and practical insights in tricuspid valve interventions in this comprehensive session. Learn about the current status and patient selection for orthotopic valve implantation, gain expert guidance on intraprocedural monitoring with step-by-step tips, and understand the critical information required for pre, intra, and...
Redefining and optimising LAA closure - LIVE Case
11 Sep 2025 – From PCR Rio Valves 2025
Supported by an unrestricted educational grant from Boston Scientific
A 78-year-old woman with atrial fibrillation and obesity (BMI 34.3), normal left ventricular function, CHADS-VASCs 5 and HAS-BLED 4, presented with severe gastrointestinal bleeding.
She underwent implantation of a Watchman FLX™ pro under local anesthesia via two right femoral...
How to optimise outcome in valve-in-valve and valve-in-mitral annular calcification patients
12 Sep 2025 – From PCR Rio Valves 2025
This session explores how to optimise outcomes in valve-in-valve and valve-in-mitral annular calcification procedures. Clinical evidence is combined with real case demonstrations, highlighting step-by-step approaches, practical strategies, and techniques to reduce risks such as left ventricular outflow tract obstruction in high-risk patients.
Redo TAVI
12 Sep 2025 – From PCR Rio Valves 2025
This session focuses on the challenges and strategies of redo TAVI, from careful planning to valve selection and tailored procedural approaches. Learn how to manage different valve platforms, optimise outcomes in valve-in-valve scenarios, and prevent complications such as coronary obstruction through real case discussions.
Mitral valve-in-valves: echocardiography and CT scan
29 Sep 2025 – From PCR Gulf Valves 2025
This session provides in-depth knowledge on imaging planning for mitral valve-in-valve procedures, focusing on echocardiography and CT scan assessment. Learn the critical role of intraprocedural imaging guidance to ensure procedural success and patient safety during mitral valve-in-valve interventions.
Mitral transcatheter edge-to-edge repair - LIVE Case
29 Sep 2025 – From PCR Gulf Valves 2025
A 65-year-old female with a history of atrial fibrillation, LAD PCI (2016), ICD implantation (2016), stroke, and insulin-dependent DM, presented with symptomatic severe secondary mitral regurgitation and poor left ventricular function (LVEF 20%). A single MitraClip was implanted under general anesthesia and TEE guidance.
LIVE Educational Case...
Advanced mitral valve TEER echocardiography
29 Sep 2025 – From PCR Gulf Valves 2025
Delve into advanced echocardiographic techniques for mitral valve TEER in this session. Gain expert knowledge on transseptal access, managing complex anatomical challenges, and practical strategies to navigate difficult and high-risk TEER procedures effectively.
Hot topics: complex structural cases on mitral stenosis, alternative access and electrosurgery
29 Sep 2025 – From PCR Gulf Valves 2025
This session highlights cutting-edge approaches to complex structural heart cases, including mitral stenosis management via balloon valvuloplasty, alternative access methods such as transcaval TAVI, and innovative solutions for failed mitral TEER procedures, providing comprehensive technical insights and case resolutions.
